---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-015839"
form_type: "8-K"
ticker: "MTVA"
cik: "0001638287"
company_name: "MetaVia Inc."
filed_at: "2024-11-18T23:59:59+00:00"
generated_at: "2026-05-29T23:05:24.394518+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# NeuroBo to rename to MetaVia Nov 29; ticker changes to MTVA

## Summary
- NeuroBo Pharmaceuticals changes legal name to MetaVia Inc., effective Nov 29, 2024.
- Nasdaq ticker symbol changes from NRBO to MTVA on the same date.
- No shareholder vote required; CUSIP and transfer agent unchanged.
- Company expects Phase 2a data for DA-1241 (MASH) in Dec 2024 and Phase 1 obesity data in Q1 2025.
- June financing of up to $70M ($20M upfront, $50M warrants) provides funding runway.

## SEC filing metadata
- accession: 0001558370-24-015839
- form_type: 8-K
- ticker: MTVA
- cik: 0001638287
- company_name: MetaVia Inc.
- filed_at: 2024-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638287/000155837024015839/0001558370-24-015839-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638287/000155837024015839/nrbo-20241115x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-015839
- JSON: https://secwatch.observer/filing/0001558370-24-015839.json
- Plain text: https://secwatch.observer/filing/0001558370-24-015839.txt

## Key facts
- Governance Changes
  MetaVia Inc.: Amended and restated bylaws to reflect the name change and other technical changes (effective 2024-11-29).
  - Change: bylaw amendment
  - Effective: 2024-11-29
  source text: the Board of Directors of the Company approved an amendment and restatement (the “Fourth Amended and Restated Bylaws”) of the Company’s Third Amended and Restated Bylaws, effective as of November 29, 2024. The Fourth Amended and Restated Bylaws reflect the Name Change, as well as certain other technical changes.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638287/000155837024015839/0001558370-24-015839-index.htm
- Governance Changes
  MetaVia Inc.: Changed legal name from NeuroBo Pharmaceuticals, Inc. to MetaVia Inc (effective 2024-11-29).
  - Change: charter amendment
  - Effective: 2024-11-29
  source text: On November 15, 2024, NeuroBo Pharmaceuticals, Inc. (the “Company” or the “Registrant”) filed a Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (“Certificate of Amendment”) with the Secretary of State of the State of Delaware to change the legal name of the Company from “NeuroBo Pharmaceuticals, Inc.” to “MetaVia Inc.,” effective as of November 29, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638287/000155837024015839/0001558370-24-015839-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.